CITIGROUP INC - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is and the CUSIP is 67424L209. A total of 13 filers reported holding OBALON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,0000.0%5000.0%0.00%
Q4 2020$1,0005000.0%0.00%
Q3 2020$05000.0%0.00%
Q2 2020$05000.0%0.00%
Q1 2020$0
-100.0%
5000.0%0.00%
Q4 2019$1,0000.0%5000.0%0.00%
Q3 2019$1,0005000.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 380,224$346,0000.10%
ARMISTICE CAPITAL, LLC 740,000$674,0000.02%
Cerity Partners LLC 155,000$141,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 33,000$30,0000.00%
WELLS FARGO & COMPANY/MN 40$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 332$00.00%
GEODE CAPITAL MANAGEMENT, LLC 11,709$10,0000.00%
CITIGROUP INC 500$00.00%
MORGAN STANLEY 700,010$637,0000.00%
View complete list of OBALON THERAPEUTICS INC shareholders